SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending following the release of pivotal Phase 3 trial data for its pancreatic cancer candidate, daraxonrasib, which significantly improved overall survival compared to standard chemotherapy. Investors and clinicians are actively discussing the transformative clinical outcomes, which have sparked heightened acquisition speculation and multiple analyst price target increases as the company advances its regulatory filings.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is trending as investors react to a U.S. Army xTech SBIR contract win for its Gemini-II APU and anticipation regarding its potential role in edge AI and defense sectors. While some community members are bullish on its specialized compute-in-memory architecture, others remain highly skeptical, frequently warning of dilution risks and questioning the competitiveness of their product compared to established industry leaders.

BlackRock, Inc. engages in the provision of investment, advisory, and risk management solutions. Its products include single-asset and multi-asset portfolios. The company was founded by Laurence Douglas Fink and Robert Steven Kapito in 1988 and is headquartered in New York, NY.

Blackrock Inc.

BlackRock is currently trending as the market scrutinizes its private credit division following reports of restricted investor withdrawals and rising loan stress in the sector. Traders are also actively debating the stock's technical position, with many analysts focusing on recent Elliott Wave analysis that identifies a critical support zone as the asset manager faces broader concerns about liquidity and potential systemic risks.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is trending ahead of its quarterly earnings report, as investors closely watch the stock for signals on the sustainability of AI infrastructure spending. Community sentiment remains polarized, with some traders highlighting its strategic partnerships as a catalyst for long-term growth, while others express caution regarding recent price volatility and high short interest.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirm is currently trending as a focal point for fintech investors, with strong sentiment driven by its resilient recurring loan revenue and the expansion of its partnership with Google's AI-driven platforms. The community is actively debating the stock's long-term valuation versus cyclical credit risks, with many traders closely monitoring its price action for signs of a major breakout.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is trending as community members rally behind network upgrades and aggressive token burn initiatives, fueling speculation about a potential supply squeeze. Discussions remain polarized, balancing high-conviction support for a long-term underdog recovery against cautionary warnings regarding the token's massive circulating supply and historical volatility.

SharonAI Holdings, Inc. operates as a holding company that develops and delivers GPU cloud computing and AI solutions. The company was founded on December 30, 2024 and is headquartered in New York, NY.

SharonAI Holdings Inc. - Ordinary Shares - Class A

SharonAI is currently experiencing intense attention and high volatility driven by a massive multi-year infrastructure contract and strategic positioning from prominent institutional investors like Leopold Aschenbrenner's Situational Awareness. The community is actively debating the stock's potential for a major short squeeze due to its tight float, with many focusing on its role as a niche 'NeoCloud' provider amid broader AI hardware demand.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

The VanEck Gold Miners ETF (GDX) remains a focal point for investors as central banks aggressively expand their gold reserves to hedge against geopolitical fragmentation and sustained inflationary pressures. The community is actively debating the sector's long-term outlook, weighing the potential for a monetary reset and fiscal stimulus against short-term volatility driven by rate hike speculation and shifting dollar dynamics.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is attracting significant attention as investors anticipate the upcoming FDA decision on the supplemental New Drug Application for Auvelity to treat agitation associated with Alzheimers disease. The community is heavily focused on the drugs clean label potential and the company's aggressive sales force expansion, viewing the pending approval as a transformative catalyst for the firm's commercial growth.

Coeur Mining, Inc. engages in the well-diversified, growing precious metals producer with a focus on generating sustainable, high-quality cash flow and returns from a balanced, prospective asset base in mining-friendly jurisdictions along with commitment to exploration and expansions. It operates through the following segments: Palmarejo, Rochester, Kensington, Wharf and Silvertip. The Palmarejo segment includes a gold-silver complex. The Rochester segment operates an open pit heap leach silver-gold mine in northwestern Nevada. The Kensington segment relates to an underground gold mine located north of Juneau, Alaska. The Wharf segment focuses on an open pit heap leach gold mine located near Lead, South Dakota. The Silvertip segment silver-zinc-lead exploration located in the state of Sonora in northern Mexico. The company was founded in 1928 and is headquartered in Chicago, IL.

Coeur Mining Inc

Coeur Mining is drawing significant community focus due to record-breaking financial performance and the anticipation surrounding its strategic acquisition of New Gold, which is expected to create a diversified gold and copper powerhouse. Investors are actively discussing the firm's strengthened cash flow profile and operational leverage as catalysts for a potential re-rating in a favorable commodities market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aptar Releases 2025 Corporate Sustainability Report

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today released its 2025 Corporate Sustainability Report entitled Progress in Motion. The report highlights activities across Aptars global operations from January 1 through...

Greif Rewards Shareholders With 10.7% Hike in Quarterly Dividend

GEF boosts its quarterly dividend 10.7%, supported by stronger free cash flow, lower leverage and a commitment to returning capital.

Aptar Named a CDP Supplier Engagement Leader for the Sixth Consecutive Year

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, was named a CDP Supplier Engagement Leader, for the sixth consecutive year. This assessment, based on information reported within the 2025 CDP reporting cycle...

Aptar to Participate in Upcoming Investor Conferences

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it will present at two upcoming investor conferences: Jefferies Global Healthcare Conference in New York, NY on Wednesday, June 3, 2026. Vanessa...

AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot

AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot...

AptarGroup Q1 Earnings Beat Estimates but Decline Y/Y, Shares Dip 1%

ATR tops Q1 earnings estimates on strong sales growth, but profit declines, pharma headwinds and margin pressure send shares down despite an upbeat Q2 outlook. 


AptarGroup (NYSE:ATR) Raised to Hold at Zacks Research

Zacks Research raised shares of AptarGroup from a "strong sell" rating to a "hold" rating in a research report on Monday...

Mitsubishi UFJ Trust & Banking Corp Decreases Stock Holdings in AptarGroup, Inc. $ATR

Mitsubishi UFJ Trust & Banking Corp trimmed its holdings in shares of AptarGroup, Inc. (NYSE:ATR - Free Report) by 60.3% in the fourth quarter, according to its most recent disclosure with the...

Wells Fargo & Company Boosts AptarGroup (NYSE:ATR) Price Target to $145.00

Wells Fargo & Company upped their price objective on AptarGroup from $144.00 to $145.00 and gave the stock an 'overweight' rating in a report on Monday...

Comerica Bank Has $3.63 Million Stake in AptarGroup, Inc. $ATR

Comerica Bank increased its position in AptarGroup, Inc. (NYSE:ATR - Free Report) by 57.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities...

AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty, Closures, and Corporate and Other. The Pharma segment sells proprietary dispensing systems, drug delivery systems, sealing solutions, pharma packaging, and services to the prescription drug industry. The Beauty segment refers to dispensing systems and sealing solutions to the beauty, personal care and home care markets. The Closures segment is involved with dispensing closures, sealing solutions and food service trays to the food, beverage, personal care, home care, beauty and other markets. The company was founded in 1940 and is headquartered in Crystal Lake, IL.

Aptargroup Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ATRAptargroup Inc.

Fundamentals

Latest ATR News